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847-4 Enhanced External Counterpulsation Reduces Angina 
and Improves Quality of Life in Elderly 
Unrevsscularizable Patients 
Georeiann C. Linnemeier, Elizabeth O. Kennard, William E. Lawson, University of 
Pittsburgh, Pittsburgh, Pennsy/vania. 
Background: When treating eldedy patients (E) (>75 years) with symptomatic oronary 
artery disease (CAD), it is unclear whether the acute risks of revasculadzatlon are coun- 
terbalanced by better long-term survival or functional outcomes. Enhanced external 
counterpulsation (EECP) is a noninvasive treatment similar to the intra-aortic balloon 
pump, which is designed to increase myocardial perfusion pressure and decrease car- 
diac workload. EECP has been demonstrated to be safe and effective in treating angina; 
however, whether it is safe and effective in E who are not considered candidates for fur- 
ther revascu(adzation is unknown. 
Methods: The study group consisted of 550 patients consecutively enrolled in the Inter- 
national EECP Patient Registry who were ~ 75 years and not considered candidates for 
further revasculadzation. 
Results: The mean age was 79.9 (+ 4.4 years). Most patients had prior revascularization: 
72% prior coronary artery bypass graft surgery, 58% prior percutanecus coronary inter- 
vention. Mean left ventricular ejection fraction was 45%, and 23% of E had an ejection 
fraction <35%. Multivessel disease was present in 85% of patients, with 87% of E report- 
ing Canadian Cardiovascular Society (CCS) angina class III or IV. Treatment was com- 
pleted as prescribed in 80% of patients, with a mean of 32 treatment hours. The rate of 
major adverse cardiac events during treatment was low (<3%). Upon completion of 
EECP treatment, E reported: significant reduction in angina (mean CCS class, pre- 3.1 
vs. post- 1.9), and significant reduction in episodes of angina (mean episodes/week, pre- 
9.4 vs. post- 2.4) and nitroglycerin use (mean, pre- 9.4 vs. post- 2.7). Of 74% of E using 
nitroglycerin at the start of treatment, 42% of E required nitroglycerin post-EECP treat- 
ment. Patient assessed quality of life scores were also significantly improved post-treat- 
ment. All changes, pre-and post-EECP were statistically significant with p<0.001. 
Conclusion: Symptomatic CAD in elderly patients is of immense public health and eco- 
nomic importance. In the group of elderly patients who are unsuitable for revasculariza- 
tion, EECP provides an innovative tool that improves functional outcome and quality of 
life. 
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847-5 White Coat Hypertension Increases Cardiovascular 
Risk in Elderly 
Jose A. Aizourua. Tulle A. Sulbaran, Egle Silva, Gladys Maestre, Centre de 
Enfermedades Cardiovasoulares, Maracaibo, Venezuela, La Universidad e/Zulia, 
Maracaibo, Venezue/a. 
Background: There are no long-term follow up studies about white coat hypertension 
(WCH) in Venezuela; on the other hand there is a controversy about the risk provided by 
this condition. The aim of this study was to establish the prognostic value of Ambulatory 
Monitoring Blood Pressure (ABPM) for cardiovascular (CV) morbidity in elderly. 
Method,=: The study included a sample of 609 subjects older than 55 years who under- 
went non-invasive ABPM when enrolled in the study and were prospectively followed 
since that moment until a nonfatal cardiovascular event occurs or the ending of the study. 
The maximal follow up time was 31.5 months (mean 20). 
Results: The comparison between morbidity rates showed a significant difference 
among normctensive (1.04 per 100 pac/yr), WCH (8.99 per 100 pac/yr) and ambulatory 
hypertension (16.76 per 100 pec/yr) groups (p < 0.01). The difference between survival 
curves was highly significant FIG 1. Night systolic ABP showed the best independent 
predictive power for CV events. Diastolic pressures were not associated to cardiovascu- 
lar events dsk. The risk for morbidity in WCH group was increased compared with that of 
normotensive group (RR 8.65; CI 95% 3.03 - 24.68; p < 0.01). Nondippers showed an 
increased risk compared to dippers (RR 1.73; CI 95% 1.03 - 2.88; p 0.03). 
Conclusion: In this elderly population, WCH is not a benign condition, but must be con- 
sidered as an important CV risk factor. Nondipper pattern showed predictive power in 
whole population for both sexes. 
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847-6 Outcome of Elderly Women With Refractory Chronic 
Angina Treated Invasively Versus Medically: 
Comparison With Elderly Men In the Prospective 
Randomized Trial of  Invasive Versus Medical Therapy in 
the Elderly (TIME) 
Gabriela M. Kuster, Matthias Pfistersr, for the TIME Investigators, University Hospital, 
Basel, Switzerland. 
Background: Women >75 years of age represent almost half the elderly coronary artery 
disease (CAD) population, yet they are severely underrepresented inclinical trials. 
Patients and Methods: We prospectively randomized 301 patients age >75 years with 
angina CCS class II-IV despite at least two antianginal drugs to coronary angiography 
and revasculadzation or to optimized medical therapy. Six months outcome assessed as 
quality of life (QoL: SF 36, Rose, Duke Activity Score Index) and adverse events (AE: 
death, myocardial infarction (MI) or hospitalisation for acute coronary syndrome) were 
compared between women and men as prespecified subgroups of the TIME study. 
Results: 44% (n=131) of the 301 patients were women. Age was 80±4 years (mean±SD) 
in both genders. More women were hypertensive (70% vs. 55%, p--0,006), and fewer 
smoked (12 vs. 51%, p<0,0001). Although angina sevedty (CCS class Ill-IV in 82% vs. 
75% of the men, n.s,) and history of prior MI (44 vs. 49%, n.s.) were similar, the rate of 
prior revasculafizations was lower in women (6% vs. 29%, p<0.001) and fewer coronary 
vessels were diseased (p<0.00t). In addition, left ventricular ejection fraction was higher 
in women (55±12 vs. 51±12, p=0.05). Despite these findings, women judged their QoL at 
baseline inferior than men (p<0.01 except for Rose). During follow-up, they showed a 
similar improvement in QoL on therapy as men, but overall, QoL remained worse in 
women. AE occurred more often in women than in men with more deaths (]o=0.03) and a 
higher rate of death and MI (p=0.01). The subgroup of medically treated women (n=64) 
suffered more AE (p<0,003), particulady non-fatal ischemic events (p<0.001) than 
women in the invasive subgroup (n=67). 
Conclusions: Eldedy women with chronic angina differ importantly from eldedy man in 
disease presentation, perception and outcome: despite similar angina and lower disease 
severity, they judge their QoL worse than men and their outcome is worse than that of 
men. Still, they benefit from revascularisation similarly. These findings suggest that other 
mechanisms than CAD severity may be relevant in determining weU-being and outcome 
in women. 
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11 56-141 Cytotoxic Aldehydes Aggravate Ventricular Dysfunction 
in an Injured Heart: Evidence From an Iron Overload 
Model of Heart Failure 
Mehrdad Yazdanpanah, Gavin Oudit, Andrea Lee, Fayez Dawood, Wen-Hu Wan, Peter 
Beckx, Peter Liu. Heart & Stroke~Richard Lewar Centre of Excellence, U of Toronto, 
Toronto, Ontario, Canada, Toronto General Hospital, UHN, Toronto, Ontario, Canada. 
BACKGROUND: Cytotoxic aldehydes, by-products of oxidative stress, are increased in 
heart failure in general, and in iron ovedoad cardiomyopathy in particular. We tested the 
hypothesis that increased aldehydes exert a direct negative influence on heart function in 
an established iron overload heart failure model. 
METHODS: On the background of cardiac iron overload, we augmented aldehyde levels 
by selective inhibition of tissue aldehyde dehydrogenase (ALDH) with disulfirem (Dis, 40 
mg/kg ip od), cyanamide (Cyn, 50 mg/kg ip od), or administration of 12 straight chain 
aldehydes (0.1 mL, 2.5 raM, ip) for 3 months in B6D2Flmice, and assessed aldehyde 
levels together with invasive and no-invasive measures of LV function. Mice were ran- 
domized to either control (C), iron load (Fe) alone or iron load with ALDH inhibitor (AIdl). 
RESULTS: Serum aldehydes increased further with ALDH inhibition (Hexanol, nmoVL, 
C:134±15 vs, Fe:261±37 vs. Dis:342±26, M±SEM, p<0.05). In rive hemodynamics using 
a Millar catheter displayed lower LV systolic pressure with ALDH inhibition (C: 96±4 vs. 
Fe: 74±3 vs Cyn: 64±2 mmHg, p<0.05, and similarly with disulfiram). FJA ratio was also 
decreased with Aldl (C:1,4±.2 vs. Fe: 1,2±.2 vs. Dis: 1.0¢.3, p<0.05). With aldehyde infu- 
sions, both +dP/dt and -dP/dt were lower (2815±547 vs 5618±776 (C), 2293±219 vs 
4255¢376 (C), p<0.05). 
CONCLUSION: The increased levels of serum aldehydes with either ALDH inhibition or 
direct infusion led to further depression of both systolic and diastolic function, suggesting 
oxidative stress contributes to the LV dysfunction in the setting of cardiac injury, and is 
not merely an innocent bystander. 
1156-142 NF-kB Activation Is Involved in Inflammatory Skeletal 
Muscle Alterations In Patients With Chronic Heart 
Failure 
Vglker Adams. Uldke Sp&te, Nicolle Kr&nkel, Gerhard Schuler, Rainer Hambrecht, 
University Leipzig, Heart Center Leipzig, Leipzig, Germany. 
Background: In advanced stages of chronic heart failure (CHF) the expression of induc- 
ible nitric oxide synthase (iNOS) in skeletal muscle (SM) may contdbute to exercise intol- 
erance and early fatigue. In vitro studies and promoter analysis demonstrated that the 
